Prolonging the stability of cetuximab (Erbitux®) and panitumumab (Vectibix®): An orthogonal assessment of physicochemical, biological and microbiological properties of original opened glass vials and diluted saline preparations-Reference-Cited by-同舟云学术

Prolonging the stability of cetuximab (Erbitux®) and panitumumab (Vectibix®): An orthogonal assessment of physicochemical, biological and microbiological properties of original opened glass vials and diluted saline preparations

Published:2024-01 Issue: Volume:649 Page:123643
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Carpanese Debora^ORCID,Rossi Valentina,Di Paolo Veronica,Quintieri Luigi^ORCID,Penna Alessandro^ORCID,Zuccolotto Gaia,Sebellin Jessica,Saran Camilla^ORCID,Pipitone Francesca,Miolo Giorgia^ORCID,De Diana Elisabetta,Realdon Nicola^ORCID,Rigamonti Nicoletta^ORCID,Di Sarra Francesca,Coppola Marina,Rosato Antonio

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference28 articles.

1. Stability of ipilimumab in its original vial after opening allows its use for at least 4 weeks and facilitates pooling of residues;Bardo-Brouard;Eur. J. Cancer,2016

2. Evaluation of the physicochemical and biological stability of cetuximab under various stress condition;Farjami;J. Pharm. Pharm. Sci.,2019

3. Distinguishing Features of Cetuximab and Panitumumab in Colorectal Cancer and Other Solid Tumors;García-Foncillas;Front. Oncol.,2019

4. Parenteral protein formulations: An overview of approved products within the European Union;Gervasi;Eur. J. Pharm. Biopharm.,2018

5. Structural properties of monoclonal antibody aggregates induced by freeze-thawing and thermal stress;Hawe;Eur. J. Pharm. Sci.,2009

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monoclonal Antibody Therapies in Cancer Immunotherapy;Advances in Medical Diagnosis, Treatment, and Care;2024-08-28